Chimeric Antigen Receptor-Engineered T Cells in Tumor Immunotherapy: From Bench to Beside
Chimeric antigen receptor-engineered T cells (CAR-T cells), a classification of cultured T cells after modification of gene engineering technology, can recognize specific tumor antigens in a major histocompatibility complex (MHC)-independent manner, consequently leading to the activation of antitumo...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Third Party Medicine International Publishing Group Co. Limited
2017-06-01
|
| Series: | Journal of International Translational Medicine |
| Subjects: | |
| Online Access: | http://www.jitm.hk/EN/abstract/abstract247.shtml |